Describe strategies to enhance CNS distribution for an existing drug.

Describe strategies to enhance CNS distribution for an existing drug.

• A. Use of lipophilicity-enhancing formulations.
• B. Prodrugs to enhance CNS penetration.
• C. P-gp inhibitors to increase CNS penetration.
• D. Use of lipophilicity-enhancing formulations, prodrugs, or P-gp inhibitors to improve CNS penetration; caution due to safety.

Answer: (D)

Crossing the blood-brain barrier is the central challenge in boosting CNS distribution. You can improve brain entry by making the drug more lipophilic to favor passive diffusion, by using a prodrug that masks polarity and is activated in the CNS, or by inhibiting efflux pumps like P-glycoprotein to reduce removal back into the bloodstream. Each tactic has trade-offs: increasing lipophilicity can raise non-specific distribution and CNS toxicity; prodrugs require reliable and safe conversion to the active drug; P-gp inhibitors can cause drug–drug interactions and alter distribution in other tissues. Combining these strategies, with careful attention to safety, offers the most practical way to enhance CNS penetration for an existing drug.

Crossing the blood-brain barrier is the central challenge in boosting CNS distribution. You can improve brain entry by making the drug more lipophilic to favor passive diffusion, by using a prodrug that masks polarity and is activated in the CNS, or by inhibiting efflux pumps like P-glycoprotein to reduce removal back into the bloodstream. Each tactic has trade-offs: increasing lipophilicity can raise non-specific distribution and CNS toxicity; prodrugs require reliable and safe conversion to the active drug; P-gp inhibitors can cause drug–drug interactions and alter distribution in other tissues. Combining these strategies, with careful attention to safety, offers the most practical way to enhance CNS penetration for an existing drug.